Peripheral Neuropathies
X linked Charcot-Marie-Tooth disease type 1
Oct. 16, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
The 30-day major adverse cardiovascular event rates reported by the various registries and studies of carotid artery stenting, organized chronologically by the year of publication, illustrate the continued decremental trend observed over time. This is likely the result of increasingly sophisticated embolic protection devices as well as growing operator experience. (Contributed by Dr. Camilo Gomez.)